Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3260)	3/31/2001 5:25:27 PM
From: NeuroInvestment	Read Replies (1) \| Respond to of 52153

Peter: I haven't ever seen a correction either. And when it's been egregiously poor reporting, like a recent NYT story on fetal cell implants, I don't even get an email response. Not that I havent made my share (or more) of errors, but I worry when a journalist's 'Top 10' list seems based on such cursory DD. Re: NPS What I was told late-January was that Phase III would start mid-year, and because Amgen did such a complete set of PhII trials behind that black curtain, it would take 12 months to complete a relatively easy Phase III. That's what I published at the beginning of February---does that constitute a 'public' statement?(g) Regards, Harry NeuroInvestment (www.neuroinvestment.com)